September 16, 2025

Lateral Positioning Reduced Hypoxaemia After Anesthesia

Lateral positioning shortens PACU stay and lowers airway intervention rates in sedated adults.

Conexiant

September 16, 2025

Photon-by-Photon Spectroscopy for Turbulent Skies

Ultra-sensitive dual-comb system delivers broadband remote sensing at attowatt scale – even during earthquakes

The Analytical Scientist

September 15, 2025

FDA Approves First Intranasal Loop Diuretic

The FDA has approved Enbumyst offering a self-administered outpatient option for managing edema in patients with heart failure, liver disease, and kidney disease.

Conexiant

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 03, 2025

FDA Approves Denosumab Biosimilars

The FDA approved Bildyos and Bilprevda are providing new options comparable to Prolia and Xgeva for osteoporosis, cancer-related bone disease, and other skeletal conditions.

Conexiant

September 03, 2025

Study Maps Delta-Like Protein 3 and SEZ6 Across Tumor Types

Researchers highlight distinct Delta-like protein 3 and seizure-related 6 homolog patterns in neuroendocrine tumors.

Conexiant

September 02, 2025

Pediatric Sepsis Outcomes by EBV Serostatus

Patients who were Epstein-Barr virus seropositive showed higher levels of immune dysregulation markers.

Conexiant

September 02, 2025

Sotatercept Maintains One-Year Gains in PAH

Ongoing follow-up evaluates long-term sotatercept use in pulmonary arterial hypertension, focusing on sustained efficacy, adverse event profiles, and clinical risk classification.

Conexiant

August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant